Lv31
300 积分 2022-10-25 加入
BAricitinib in patients with SystemIC Sclerosis (BASICS): a prospective, open-label, randomised trial
2小时前
已完结
Nerandomilast in Patients with Progressive Pulmonary Fibrosis
4天前
已完结
Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment—an expert group consensus statement
4天前
已完结
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trial
6天前
已完结
Emergence of ceftazidime-avibactam resistance through in-vivo blaKPC-2 to blaKPC-33 conversion during treatment of ST11 Klebsiella pneumoniae associated infections
17天前
已完结
Emergence of Cefiderocol Resistance in Carbapenem-Resistant Escherichia coli ST167 Prior to Clinical Use: A Multifactored Resistance Landscape
23天前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
24天前
已完结
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
24天前
已完结
Therapeutic options for carbapenem-resistant Acinetobacter baumannii infections
27天前
已完结
Impact of appropriate antimicrobial therapy on patient outcomes and antimicrobial use: a sub analysis of the DIANA Study Dataset
1个月前
已完结
皖公网安备34019202002308
